Rheumatology in a time of Coronavirus: lessons from our early experiences

QJM. 2020 Oct 1;113(10):715-716. doi: 10.1093/qjmed/hcaa163.

Authors

O Cronin¹, A Horne¹, S H Ralston^{1

2}

Affiliations

¹ From the Rheumatic Diseases Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.
² MRC Institute of Genetics and Molecular Medicine, Centre for Genomic and Experimental Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XU, UK.

No abstract available

Publication types

Letter

MeSH terms

Antirheumatic Agents / therapeutic use*
Betacoronavirus
COVID-19
Comorbidity
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Disease Management
Humans
Pandemics
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*
Rheumatic Diseases / epidemiology
Rheumatic Diseases / therapy*
Rheumatology / organization & administration
SARS-CoV-2

Substances

Antirheumatic Agents